EDITOR, Commenting on our paper, which described an apparent halving in the incidence of cystic fibrosis in East Anglia,' Dr Coles and colleagues suggest that during the last three years of the reported study, a substantial number of patients with cystic fibrosis might have remained undiagnosed because of over reliance on the efficiency of the screening test.2 This is an implausible explanation for our observations. Such an occurrence would require either a drastic deterioration in the analytical performance of the assay, which is not supported by the results of the external or internal quality control procedures conducted throughout this period, or an abrupt change in the pathophysiology responsible for the raised blood immune reactive trypsin (IRT) concentrations in the newborn who have inherited cystic fibrosis during this later period. Furthermore, there is no evidence to suggest that East Anglia's paediatricians have, over the years, become complacent about achieving the earliest possible diagnosis in that small percentage of cystic fibrosis patients not detected by screening. We are confident in this assertion from the number of inquiries received from every ward and clinic in the region seeking to confirm that routine neonatal IRT screening has been carried out on infants and children presenting with symptoms, in conjunction with the continuing usage of the excellent sweat testing facilities throughout the region, and more recently with the increasing use of the facility to test for the more common cystic fibrosis genotypes on DNA extracted from stored neonatal blood spots.
Secondly, all the cases were diagnosed by IRT assay. Dr Coles and colleagues refer to the figure of 68% of cases being identified by IRT assay alone. The remainder of cases had clinical features which might have led to the diagnosis, in addition to an abnormal IRT assay.
There is thus no evidence to suggest that under ascertainment explains the declining incidence. We agree that it will be important to continue monitoring the incidence of cystic fibrosis in East Anglia. 
